South Korea's health ministry and the WHO announced the AI Healthcare Seoul Declaration at the 2026 World Bio Summit

Key takeaways

• The release states no duty, deadline or sanction. Our reading is that the declaration is non-binding.
• The ministry says it has four parts, from technology and investment to implementation and follow-up.
• The full text is to be released through a summit programme book, which we did not see.
• The ministry says implementing countries are to respect domestic law and national context.

What is the AI Healthcare Seoul Declaration, and is it binding?

It is a joint declaration; the release does not describe it as legislation. According to the Ministry of Health and Welfare release, Minister Jung Eun-kyeong and WHO Director-General Tedros Adhanom Ghebreyesus announced it at the opening ceremony of the 2026 World Bio Summit in Seoul, which the Korean government and the WHO host together and which ran on 21 and 22 October 2026. The release gives its full title as 책임 있는 혁신과 글로벌 연대를 위한 AI 헬스케어 서울선언문.

The release does not state the declaration's legal status and mentions no penalty, filing or deadline. It lists, as part of implementation, that countries should respect domestic law and national context when implementing the declaration. On that basis we treat it, as the desk's reading, as non-binding soft law. The ministry itself describes it as the first joint declaration on AI use issued by the Korean health ministry together with a WHO Director-General.

What does the ministry say the declaration contains?

The release says the main content is an emphasis that AI's benefits should reach everyone, together with a call for safe and responsible AI use and for international solidarity in practice. It then summarises four parts. These are the ministry's summary, not the declaration text.

The ministry says the full text will be made public through the digital programme book handed to summit participants. We did not open that book.

What did each side say at the summit?

The release says Minister Jung stressed that the fruits of AI innovation should not be held by particular countries or groups and should be shared across geographic and socioeconomic barriers, in the spirit of what the ministry calls "AI basic medical care". It quotes her at the closing as calling the declaration a "historic promise" to put human life and dignity first. The Second Vice Minister is quoted as saying it was an occasion to pledge efforts so AI benefits reach all humanity.

On the WHO side, the release says Dr Tedros emphasised that health innovation has real value when it narrows gaps between countries and ensures equitable access, and expressed a will to keep working closely with the Korean government. These are the ministry's accounts of the remarks. We did not open any WHO statement or transcript.

What does it mean for digital-health companies and AI governance leads?

The release states no obligation for you. Read the four parts as the policy priorities the ministry summarises, in particular proportionate oversight across the AI life cycle, accountability for medical AI, clinician AI skills and respect for national law.

For teams that already map WHO guidance, such as our note on the WHO large multi-modal model guidance, the declaration reads as a political companion rather than a technical standard. Korea's medical-device rules sit in separate instruments; the MFDS generative AI medical device guideline is guidance, not the underlying legislation. The release does not make the declaration a source of any requirement, so do not cite it as one.

What should teams do now?

Treat this as a monitoring item.

• Add the declaration to your policy watch list under WHO and Korea, noting that the release states no obligation.
• Request the full text from the summit programme book or the ministry before quoting any clause.
• If you sell into Korea, keep tracking the instruments that carry legal duties, which the release does not identify.
• Note the follow-up: the ministry says the summit's Leaders' Dialogue was to discuss measures for turning the declaration into concrete practical tasks. The release does not say what, if anything, would follow.

What are the key dates and parties?

What we did not verify

What we opened: the Korean-language ministry press release as republished on the Korea Policy Briefing site, and its PDF attachment, on 25 October 2026 (UTC).

What we did not open: the declaration text itself, the summit programme book, any WHO release or statement, and any English version of the release. Every description of the declaration here is the ministry's summary, and the quoted Korean title and phrases are from that release. The Korean summary wording is our paraphrase in English.

What we refuse to claim: that the declaration is binding or non-binding as a matter of law (non-binding is our reading), that it sets any standard or deadline, how many countries or bodies signed, what the WHO itself says it contains, or any effect on Korean law or on medical-device approvals.

Related briefings

• AI regulation news hub
• Asia-Pacific AI regulation tracker
• WHO guidance on large multi-modal models in health
• MFDS guideline on generative AI medical devices
• Korea AI Act high-impact AI duties, including health
• Singapore MOH and HSA health AI guidelines update